Covalon Technologies Ltd. (COV.V)

CAD 2.35

(0.43%)

Total Debt Summary of Covalon Technologies Ltd.

  • Covalon Technologies Ltd.'s latest annual total debt in 2023 was 1.56 Million CAD , down -27.95% from previous year.
  • Covalon Technologies Ltd.'s latest quarterly total debt in 2024 Q3 was 1.07 Million CAD , down -14.02% from previous quarter.
  • Covalon Technologies Ltd. reported annual total debt of 2.16 Million CAD in 2022, down -16.3% from previous year.
  • Covalon Technologies Ltd. reported annual total debt of 2.59 Million CAD in 2021, down -87.61% from previous year.
  • Covalon Technologies Ltd. reported quarterly total debt of 1.25 Million CAD for 2024 Q2, down -8.83% from previous quarter.
  • Covalon Technologies Ltd. reported quarterly total debt of 1.37 Million CAD for 2024 Q1, down -11.87% from previous quarter.

Annual Total Debt Chart of Covalon Technologies Ltd. (2023 - 2005)

Historical Annual Total Debt of Covalon Technologies Ltd. (2023 - 2005)

Year Total Debt Total Debt Growth
2023 1.56 Million CAD -27.95%
2022 2.16 Million CAD -16.3%
2021 2.59 Million CAD -87.61%
2020 20.9 Million CAD 15.5%
2019 18.09 Million CAD 1085.2%
2018 1.52 Million CAD 0.0%
2017 - CAD 0.0%
2016 - CAD -100.0%
2015 846.46 Thousand CAD 28.15%
2014 660.51 Thousand CAD 28.0%
2013 516.01 Thousand CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD 0.0%

Peer Total Debt Comparison of Covalon Technologies Ltd.

Name Total Debt Total Debt Difference
Arch Biopartners Inc. 5.01 Million CAD 68.852%
Hemostemix Inc. 4.32 Million CAD 63.844%
Universal Ibogaine Inc. 1.73 Million CAD 10.083%
Kane Biotech Inc. 8.27 Million CAD 81.12%
MedMira Inc. 9.27 Million CAD 83.147%
Marvel Biosciences Corp. 1 Million CAD -56.247%
NervGen Pharma Corp. 197.19 Thousand CAD -692.365%
XORTX Therapeutics Inc. 15.17 Thousand CAD -10194.953%